Significant Investment in Drug Discovery Driving the North American Drug Discovery Informatics Market

Published: Mar 2021

The North American drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). Rising investment by the research institutes and pharmaceutical companies for the drug discoveries is further projected to create significant growth to the market in the region. The pharmaceutical companies whether they are key market players or start-ups are basically recognized by their increased drug discovery and R&D efforts that generate large volumes of data. The data originates from several phases of drug development, including the preclinical trial phase, drug approval phase, and marketing and post-sales phase.  Therefore, the rising amount of drug discovery-related data further projected to provide significant adoption of analytics tools in the region.

Browse the full report description North American Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/north-american-drug-discovery-informatics-market

Moreover, the presence of major pharmaceuticals and IT companies in the region further provides ample opportunity to the market. For instance, in September 2019, Novartis and Microsoft announced a significant move to entrench data science and AI within its business. Both the companies partnered for the creation of an AI Innovation Lab that particularly focuses on personalized therapies for macular degeneration, cell and gene therapy, and drug design. In May 2018, Roche in partnership with IBM Watson Health uses real-world data for the prediction of chronic kidney disease in patients with diabetes. Thus, these collaborations between IT and pharmaceutical companies further provide significant scope for the drug discovery informatics market.  

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Function and by End-User

Regions Covered

US and Canada

Key Companies Profiled

Charles River Laboratories, Inc., Cognizant, IBM Corp., OpenEye Scientific Software, ChemBridge Corp., and others

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected region/segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

North American Drug Discovery Informatics Market – Segmentation

By Function

  • Docking
  • Molecular Modeling
  • Libraries and Database Preparation
  • Sequencing and Target Data Analysis
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others (Research Institutes) 

North American Drug Discovery Informatics Market – Segmentation by Geography 

  • US
  • Canada

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-drug-discovery-informatics-market